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Abstract
Purpose
This paper describes the study design, methodology, cohort profile and self-reported dis-
eases in the ophthalmological branch of the Gutenberg Health Study (GHS).
Methods
The GHS is an ongoing, prospective, interdisciplinary, single-center, population-based co-
hort study in Germany. The main goals of the ophthalmological section are to assess the
prevalence and incidence of ocular diseases and to explore risk factors, genetic determi-
nants and associations with systemic diseases and conditions. The eye examination at
baseline included a medical history, self-reported eye diseases, visual acuity, refractive er-
rors, intraocular pressure, visual field, pachymetry, keratometry, fundus photography and
tear sampling. The 5-year follow-up visit additionally encompassed optical coherence to-
mography, anterior segment imaging and optical biometry. The general examination includ-
ed anthropometry; blood pressure measurement; carotid artery ultrasound;
electrocardiogram; echocardiography; spirometry; cognitive tests; questionnaires; assess-
ment of mental conditions; and DNA, RNA, blood and urine sampling.
Results
Of 15,010 participants (aged 35-74 years at the time of inclusion), ocular data are available
for 14,700 subjects (97.9%). The mean visual acuity (standard deviation), mean spherical
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equivalent, median decimal visual acuity, and mean intraocular pressure were 0.08 (0.17)
logMar, -0.42 (2.43) diopters, 0.9 and 14.24 (2.79) mm Hg, respectively. The frequencies of
self-reported strabismus, glaucoma, surgery for retinal detachment and retinal vascular oc-
clusions were 2.7%, 2.3%, 0.2% and 0.4%, respectively.
Conclusions
The GHS is the most extensive dataset of ophthalmic diseases and conditions and their risk
factors in Germany and one of the largest cohorts worldwide. This dataset will provide new
insight in the epidemiology of ophthalmic diseases and related medical specialties.
Introduction
Several epidemiological studies have reported the prevalence, incidence and risk factors of
major ophthalmic diseases. However, there may be large differences between populations and
even within the same population at different points in time [1]. This variability might be due to
demographic differences or genetic and environmental factors, or it might be partly explained
by methodological differences [2, 3].
Knowledge of the precise epidemiological features of a population is essential for planning
the future use of medical resources [4]. As population age and environmental risk factors
change, thorough epidemiological research is necessary to acquire the knowledge to ensure suf-
ficient medical care, public health screenings and the efficient use of medical resources.
Several major ophthalmological diseases are linked to systemic diseases such as atheroscle-
rosis, diabetes mellitus or arterial hypertension. Changes in the prevalence, incidence and treat-
ment of those systemic risk factors will change the occurrence and course of the associated
ophthalmological diseases. Furthermore, there is eminent need to investigate the association
between eye diseases and related cardiovascular, neurodegenerative, metabolic and
immunological conditions.
The ophthalmological branch of the Gutenberg Health Study (GHS) was designed and es-
tablished to
a. estimate the prevalence and incidence of major ocular diseases (such as glaucoma, age-related
macular degeneration, diabetic retinopathy) and their risk factors in Germany, which is the
European country with the largest population,
b. report distribution on biometric ocular parameters within a population-based study design,
c. provide data on associations between ocular parameters (e.g. intraocular pressure, refractive
error, central retinal thickness) and diseases (e.g. diabetic retinopathy, age-related macular
degeneration, glaucoma) with in particular cardiovascular parameters and diseases, genetic
variants, mental and general conditions,
d. establish a large biobank for future research projects.
This article describes the study structure and methods of the ophthalmic branch of the GHS,
presents its other major parts and research topics and provides data on the cohort profile and
self-reported ocular diseases.
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Materials and Methods
The Gutenberg Health Study (GHS) is an ongoing population-based, interdisciplinary, pro-
spective, single-center cohort study at the medical center of Johannes Gutenberg University
Mainz in Germany. All participants provided informed consent. The study design followed the
tenets of the Declaration of Helsinki. The GHS was approved by the local ethics committee
(Ethics Commission of the State Chamber of Physicians of Rhineland-Palatinate) and by the
local and federal data safety commissioners.
Study aim
The GHS aims to assess the prevalence and incidence of cardiovascular, metabolic, ophthalmo-
logical and mental disorders in the population of the city of Mainz and the Mainz-Bingen dis-
trict in the mid-western part of Germany (Rhine-Main region). The primary goal of the study
is to improve the prediction of disease by taking into account psychosocial, environmental and
lifestyle risk factors, subclinical disease, protein pattern and genetic variants. The sample size
calculation was based on the primary endpoints of the study, myocardial infarction and
cardiovascular death.
Study design
A pilot study of feasibility and for establishing process sequences was conducted between 2005
and 2007. The baseline assessment of the population-based cohort of 15,010 men and women
aged 35 to 74 at the time of inclusion started in April 2007 and was completed in March 2012.
An interdisciplinary examination protocol was applied, including general, anthropometric, car-
diovascular, psychological and ophthalmological tests lasting 5 hours. A computer-assisted in-
terview and questionnaires elucidated the classic psychosocial, environmental, physical activity,
nutritional and lifestyle risk factors. Two and a half years after the baseline examination, the par-
ticipants were contacted for a follow-up investigation by computer-assisted telephone interview,
which recorded the end-points, medical history and self-reported medication and lifestyle fac-
tors. Five years after the baseline visit, the participants are invited to the study center for a fol-
low-up visit, comprising of repeated measurements with an extended examination protocol
lasting nearly 6 hours. A second telephone interview will take place 7.5 years after the baseline
visit. Furthermore, a 10-year follow-up of the whole cohort is planned commencing in 2017.
Study population
Out of all residents of the city of Mainz (n = 196,425) and the district of Mainz-Bingen
(n = 201,371) 210,867 subjects aged 35 to 74 years at the time of inclusion were eligible to par-
ticipate in the GHS. Of these, a sample of 35,008 subjects, stratified by gender, decade of age
and residence (rural vs. urban), was selected via the local residents’ registration offices. A study
sample of intended 15,000 participants was drawn in waves of equal stratification to meet a
standardized recruiting and to allow defined subsample analyses after inclusion of 5,000 and
10,000 subjects. The exclusion criteria were insufficient knowledge of the German language
and physical or mental inability to participate in the examinations at the study center. A total
of 15,010 subjects were enrolled in the study sample and the overall response rate was 60.3%.
Enrollment methods
The study participants were selected randomly from local residents’ registration offices. Accord-
ing to German law, it is mandatory for each individual to register his/her personal and residential
data within a week after moving to or from any location within Germany. Selected participants
Gutenberg Health Study and Ophthalmic Study Design
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Table 1. Summary of non-ophthalmological tests, questionnaires and interviews of the Gutenberg
Health Study (baseline examination).
General data Anthropometry
Body temperature
Current weather data
Physical activity
Nutrition
Medications
Cardiology, angiology and
pulmonology tests
Electrocardiography
Echocardiography
Blood pressure and pulse
Sonography of neck vessels
Neurocardiac regulation
Occlusion pressure measurement and ankle brachial index
Spirometry
Flow-mediated vasodilation and arterial stiffness, volume
plethysmography of ﬁnger artery, digital photo plethysmographical
pulse curve analysis
Carbon monoxide in alveolar air
Laboratory tests Blood count, electrolytes, renal and liver function parameters, blood
fat parameters
Basic and special blood coagulation parameters, cardiac enzymes
Inﬂammatory parameters, selected vitamins and hormones
Parameters of oxidative stress, basic urine tests
Psychological and social data Social demographic data
Access to and use of medical care
Cancer prevention
Gender-related questions
Full medical history
Classic cardiovascular risk factors
Disease-related complaints and pathologies
Family medical history
Children
Health care behavior
Hobbies
Smoking, passive smoking, alcohol consumption
Occupational history
Exposure to airborne pollutants and noise
General happiness and environmental factors
Domestic environment
Neurocognitive function
Personality, psychiatric diseases and mental disorders
Everyday duties
Social integration
Psycho-social stress at work
Life events
Visual quality of life
Biomaterials Plasma, serum, DNA, RNA, urine, gingival sulcus swab, lacrimal ﬂuid
doi:10.1371/journal.pone.0120476.t001
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were contacted by letter and invited for the baseline examination. If they did not respond, then
the recruitment team contacted them by phone. Persons, who were unable to come to the study
center or did not want to participate, were asked to respond to some questions about demo-
graphics and their reasons for non-participation (non-responder questionnaire). A staged con-
sent process was established for non-invasive testing, blood sampling and genetic assessments.
The participants could withdraw from the study at any point without a need for justification.
Consenting withdrawal immediately resulted in disposal of all bio-samples.
Data management / Steering committee
The data were collected, managed and analyzed at a central data bank under the supervision
and responsibility of the GHS study coordinator. Plausibility checks and data quality controls
were performed on a regular basis. The GHS steering committee decided on the internal and
external access and use of the data and biomaterials.
General and non-ophthalmological tests
All data acquisition and tests were performed in a standardized manner by trained and certified
personnel at the GHS study center. The sequence of examinations and interviews was predeter-
mined. Table 1 gives an overview of non-ophthalmological tests, questionnaires and interviews.
Ophthalmological examinations
Table 2 summarizes the ophthalmological examinations of the GHS, which lasted 25 minutes
per participant and were performed between 11 a.m. and 8 p.m. During the baseline visit all
Table 2. Gutenberg Health Study eye examinations at baseline (2007–2012) and at the 5-year follow-
up (2012–2017).
Manufacturer/Methods/Speciﬁcations
Baseline Follow-up
Autorefraction Humphrey Automated Refractor/Keratometer
(HARK) 5991Corrected visual acuity
Pachy- and keratometry Pachycam2 Pentacam2
Visual ﬁeld screening FDT Humphrey Matrix Perimeter1
Intraocular pressure Nidek NT-2000 Noncontact tonometer3
Biometry - Lenstar LS 9004
Slit-lamp examination Haag-Streit BM 9004 -
Fundus photography Visucam PRO NM,1 45° ﬁeld fundus, 30° ﬁeld
optic disc and macular area
Optical Coherence Tomography Spectralis-OCT5, 6 Spectralis-OCT5
Schirmer II Tear Test7/ collection of tear ﬂuid Oxybuprocaine-hydrochloride 0,4% eye drop8,
Schirmer Tear Test Ophthalmic Strips9
1Carl Zeiss Meditec AG, Jena, Germany
2Oculus, Wetzlar, Germany
3Nidek Co., Japan
4Haag Streit, Koeniz, Switzerland
5Heidelberg Engineering, Heidelberg, Germany
6part of the examination since 2011
7performed only at baseline visit
8OmniVision, Puchheim, Germany
9Optitech Eyecare, Allahabad, India,
doi:10.1371/journal.pone.0120476.t002
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investigations were performed by a board-certified ophthalmologist. Starting with the 5-year
follow-up in April 2012, all examinations were being performed by well-trained and certified
study assistants. The study protocol was modified with the follow-up phase; all changes are
shown in Table 2.
Refraction and Visual acuity. Autorefraction and corrected visual acuity were measured
using a Humphrey Automated Refractor / Keratometer (HARK) 599 (Carl Zeiss AG, Jena, Ger-
many). The right eye was measured first. After obtaining autorefraction, corrected visual acuity
was recorded using the built-in Snellen charts, ranging from 20/400 to 40/20 (decimal 0.05 to
2.0). If the visual acuity was below 20/400 (decimal 0.05), further testing was performed using a
visual acuity chart at a distance of one meter up to 20/800, and further down to counting fin-
gers, hand movements, light perception and no light perception at the lowest level. The spheri-
cal equivalent was calculated as the spherical correction value plus half the cylindrical power.
Intraocular pressure. Intraocular pressure was measured with a noncontact tonometer
and automatic air-puff control (Nidek NT-2000; Nidek, Co., Gamagori, Japan). Always starting
with the right eye, the mean of three measurements within a 3-mmHg range was obtained for
each eye.
Visual field testing. Frequency doubling technology (FDT) Humphrey Matrix Perimeter
was used for visual field testing (program N-30-5). The participants were asked whether they
had any experience with visual field testing (yes/no) and started the test with their right eye,
while those with an odd study ID number started with the left eye. To allow the participant to
relax, the measurement of corneal thickness (described below) was performed in between the
visual field testing of the first and the second eye. Subjects with a refractive error between +5.0
and -5.0 diopters spherical equivalent underwent the examination without correction; subjects
with a refractive error higher or lower than +5.0 or -5.0 diopters spherical equivalent used their
corrective devices (glasses or contact lenses). If defects with a threshold of either one abnormal
cluster/field with P<1% or two adjacent clusters/fields with P<5% became apparent, the exam-
ination was immediately repeated for the affected eye. The examination result was promptly
classified as a) normal or b) conspicuous.
Pachymetry / Keratometry. A noncontact, Scheimpflug-based optical device (Pachycam,
Oculus, Wetzlar, Germany) was used to measure the corneal thickness and curvature during
the baseline examination of all participants. Only measurements with a quality score above
90% were accepted. Pachymetry is based on Scheimpflug images of a horizontal 4-mm section
and reveals the central and thinnest corneal thicknesses. The Pachycam has an integrated ker-
atometer that measures the central K-value as well as the K-values in the central 30°. Beginning
with the 5-year follow-up, we replaced the Pachycam with the Pentacam HR (Oculus, Wetzlar,
Germany) for corneal thickness measurements and keratometry. The Pentacam uses the same
measurement technology, but it provides additional data on the architecture of the anterior
segment of the eye (see anterior segment tomography). All of these tests started with the
right eye.
Posterior segment photography. A Visucam PRO NM nonmydriatic fundus camera (Carl
Zeiss AG, Jena, Germany) was used to take three digital fundus pictures through a non-
pharmacologically dilated pupil. The participants were positioned in a darkened room to allow
for natural pupil dilation in preparation for posterior segment photography. Two images were
centered on the optic disc (30° and 45° field) and one on the macula (30°). We always started
with the right eye. At baseline, the ophthalmologist conducted a simple evaluation of the fun-
dus pictures according to the parameters listed in Table 3.
Slit-lamp biomicroscopy of the anterior segment. A slit-lamp examination was per-
formed with undilated pupils in a darkened room to detect pathologies of the anterior segment.
Table 3 provides a summary of recorded parameters and conditions.
Gutenberg Health Study and Ophthalmic Study Design
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Anterior segment tomography. Non-contact anterior segment tomography was intro-
duced to the study protocol in April 2012 as the 5-year follow-up testing commenced. The Pen-
tacam HR (Oculus, Wetzlar, Germany) uses an automatically rotating Scheimpflug camera to
measure anterior segment architecture, including the entire cornea, anterior chamber and lens.
The Pentacam provides data on the following parameters: central corneal radii, corneal thick-
ness and asphericity, colored maps of curvature and elevation, chamber angle, volume and ele-
vation, as well as lens transparency. Pharmacological pupil dilation was not applied. Photo
documentation was performed on the right eye first.
Ocular biometry. Non-contact optical biometry was added to the study protocol in April
2012, commencing with the 5-year follow-up. Lenstar LS900 (Haag-Streit, Koeniz, Switzer-
land) employs optical low-coherence reflectometry technology to capture the ocular globe's
axial dimensions. A single measurement yields data on the following parameters: central corne-
al thickness, keratometry, white-to-white corneal distance, pupil diameter (in darkened room),
lens thickness, anterior chamber depth, the ocular globe's axial length, visual axis eccentricity
and retinal thickness (distance between internal limiting membrane and retinal pigment epi-
thelium). The right eye was measured first.
Optical coherence tomography (OCT). Spectral domain optical coherence tomography
was performed with the SPECTRALIS (Heidelberg Engineering, Heidelberg, Germany). The
scans were taken through non-pharmacologically dilated pupils in the darkened examination
room. One macular volume scan (a modified posterior pole scan) with enhanced depth imag-
ing (EDI) and two optic disc scans—an optic nerve head volume scan with EDI and a peripapil-
lary retinal nerve fiber layer (RNFL) scan—were conducted.
Tear sampling / Biobanking. Tear fluid samples were taken from both eyes of each partic-
ipant using Schirmer’s Tear Ophthalmic strips (Optitech Eyecare, Allahabad, India) one min-
ute after application of local anesthetic drops of Oxybuprocaine-hydrochloride 0.4%
Table 3. Summary of recorded ophthalmic parameters in the electronic case report file (eCRF, base-
line examination).
Oculomotoric
characteristics
Eye position according to corneal reﬂexes
Heterotropia related to nerve palsy
Eyelid Grading of blepharitis (normal/mild/moderate/severe)
Lid position (normal/entropion/ectropion)
Anterior segment Conjunctiva (hyperemia, LIPCOF, pinguecula)
Cornea (general pathologies)
Anterior chamber (cells, ﬂare)
Iris (color, atrophic areas, pigment dispersion, rubeosis, synechiae)
Lens (status, cataract, secondary cataract, pseudoexfoliation)
Posterior segment Pathologies in general (yes/no)
Cone at the optic disc (yes/no)
Glaucomatous disc atrophy (no/suspicious/beginning/advanced)
Other optic nerve atrophies (yes/no)
Hypertensive retinopathy (grading according to Keith-Wagener-Barker
classiﬁcation [32])
Macular drusen (yes/no)
Age-related macular degeneration (no/dry/geographic atrophy/wet/scar)
Diabetic retinopathy (no/mild/moderate/proliferative)
Retinal vein occlusion (no/branch/hemi-central/central)
Retinal arterial occlusion (no/branch/hemi-central/central)
Retinal detachment (yes/no)
doi:10.1371/journal.pone.0120476.t003
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(OmniVision, Puchheim, Germany). The strips were placed in the lower conjunctival sac for
three minutes. If the strip became saturated before the scheduled end of the test, it was immedi-
ately removed from the conjunctival sac. At the baseline visit, the ophthalmologist also classi-
fied the amount of fluid into three categories a) normal, b) slightly reduced or c) severely
reduced tear production. As all biomaterials, tear samples are stored at -80°C in two segregated
rooms using a standardized and partially automatized storing system. The temperature is
monitored electronically.
Visual Functioning Questionnaire and family history of age-related macular degenera-
tion and glaucoma. The German version of the “National Eye Institute Visual Functioning
Questionnaire 25” (NEI VFQ-25) was used [5]. During the computer-assisted personal inter-
view (CAPI), all participants were asked whether they were aware of any age-related macular
degeneration or glaucoma in their family history (parents or siblings).
Self-reported eye diseases
Self-reported eye diseases were extracted from the patient history collected along with the eye
examination. Every participant was asked if they suffer from any kind of glaucoma, macular
degeneration or any other eye disease. The diseases were clustered to their clinical and colloqui-
al terms and analysed respectively.
Classification of major eye diseases
The definitions to detect glaucoma [6], age-related macular degeneration [7, 8] and diabetic
retinopathy [9] are listed in Table 4.
Genetic analyses
Genomic DNA extraction was obtained from two buffy-coated EDTA blood samples from
each participant. The DNA was extracted according to Miller's method [10]. DNA samples
from the first 5000 GHS participants were genotyped using the Affymetrix GeneChip Ge-
nome-Wide Human SNP Array 6.0 in batches of 94 GHS samples, including one reference ge-
nomic DNA by Affymetrix (Ref. 103, 50 ng/μl) and one negative control without genomic
DNA per batch[11]. Total RNA was isolated from monocytes (first 1700 participants) and pe-
ripheral blood mononuclear cells (all remaining participants). RNA was isolated only for those
participants presenting at the study center during the morning session.
RNA was isolated within 24 h after blood sampling to ensure rapid sample processing.
Monocytes were separated from whole blood, and RNA was prepared as described previously
[11]. The integrity of the entire RNA was assessed through analysis on an Agilent Bioanalyzer
2100 (Agilent Technologies, Böblingen, Germany). Samples with an RNA-Integrity number
(RIN) less than seven were excluded from further analyses.
Transcriptome analyses of RNA were performed for 2200 participants using an Illumina
Ht-12 BeadChip V3 (n = 1 700) and the Affymetrix GeneChip Human Exon 1.0 ST Array
(n = 500) [11, 12]. Further genetic testing will be possible using the stored biosamples. We plan
Table 4. Definition of glaucoma, age-related macular degeneration and diabetic retinopathy in the Gu-
tenberg Health Study.
Disease Deﬁnition
Glaucoma ISGEO glaucoma classiﬁcation [6]
Age-related Macular Degeneration Rotterdam Eye Study classiﬁcation [7, 8]
Diabetic Retinopathy Early Treatment Diabetic Retinopathy Study (ETDRS) [9]
doi:10.1371/journal.pone.0120476.t004
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to use next-generation sequencing approaches for further genetic analyses of the DNA and
RNA samples. Furthermore, sequencing of miRNA in the total RNA samples as well as epige-
netic assessments will be performed.
Quality assurance
All study-related activities were performed according to “Good Clinical Practice”, “Good Epi-
demiological Practice” and the tenets of the declaration of Helsinki. Standard operating proce-
dures (SOPs) were available for all tests, and the sequence of study-related activities was
predetermined and is binding. The SOPs were verified and set during the pilot phase of the
study and between the end of the baseline examination and the beginning of the 5-year follow-
up. A central data management team is in charge of performing plausibility tests and descrip-
tive statistics on a regular basis.
Cardiovascular risk factor assessment
Cardiovascular risk factors (CVRFs) were defined as follows: Smoking was dichotomized into
non-smokers (never smokers and ex-smokers) and smokers (occasional smokers and smok-
ers). Arterial hypertension was diagnosed if antihypertensive drugs were taken, if the mean sys-
tolic blood pressure was140 mmHg in the 2nd and 3rd standardized measurement after 8
and 11 minutes of rest or if the mean diastolic blood pressure was90 mm Hg in the 2nd and
3rd standardized measurement after 8 and 11 minutes of rest. Diabetes was stated for individu-
als, who at least hold one of the following conditions: (a) definite diagnosis and treatment of di-
abetes by a physician, (b) a blood glucose level126 mg/dl at the baseline examination after
overnight fasting of at least 8 hours or (c) a blood glucose level of200 mg/dl at the baseline
examination after a fasting period of at least 8 hours. Obesity was determined as a body mass
index (BMI)30 kg/m². Dyslipidemia was defined as a definite diagnosis of dyslipidemia by a
physician or a LDL/HDL-ratio of3.5. Anthropometric measurements were performed with
calibrated digital scales (Seca 862, Seca, Hamburg Germany), a measuring stick (Seca 220, Seca,
Hamburg, Germany) and a waist-measuring tape.
Self-reported cardiovascular diseases
Self-reported cardiovascular disease data were collected from computer-assisted
personal interviews.
Statistical analyses
All data underwent quality control by a central data management team and were checked for
completeness and correctness by predefined algorithms and quality plausibility controls. Prev-
alences, rates and mean values are always presented for the study sample (no special indication,
only in tables indicated as “unweighted”) and weighted for the local population in the city of
Mainz and the Mainz-Bingen district (indicated as “weighted”) because the older age decade
was overrepresented in our study sample. Weighted data are necessary to provide population-
based results and to achieve comparability to other population-based data.
Results
After completing a pre-study phase, the study began in 2007, and the baseline examination was
completed in March 2012. The 5-year follow-up of the cohort started in April 2012. The GHS
cohort comprised a total of 15,010 participants.
Gutenberg Health Study and Ophthalmic Study Design
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Of these, 14,700 participants or 97.9% of the whole study sample attended the eye examina-
tion. Due to unavailability of ophthalmological examining personnel (e.g. sickness leave), 310
attendees did not undergo the eye examination. The age distribution of the examined and non-
examined subjects is presented in Tables 5 and 6, respectively. The participants’mean age, the
weighted mean age and the non-examined subjects mean age was 55.0 (standard deviation
±11.1, range 35–74) years, 52.6 (±11.1) years and 56.3 (±10.8) years, respectively. Men were
slightly overrepresented, with 7,420 men (50.5%) versus 7,282 women (49.5%), weighted as
7,317.3 (49.8%) and 7,382.7 (50.2%), respectively.
The prevalence of arterial hypertension was 49.6% (weighted prevalence 45.1%; non-
examined subjects 58.1%), diabetes mellitus 7.5% (6.3%; 8.8%), obesity 25.2% (24.2%; 25.4%),
and of smoking 19.4% (20.7%; 19.7%) among the participants attending the eye examination.
A summary of the ocular characteristics of the investigated participants is shown in Table 7.
The major findings were a mean visual acuity of 0.08 logMar (weighted 0.07) and a mean
spherical equivalent, calculated as the sphere plus half of the cylinder, of -0.42 ± 2.43 diopters
(weighted -0.56 ± 2.44 diopters). Median decimal visual acuity was 0.9 (weighted 1.0). The
mean intraocular pressure was 14.24 ± 2.79 mmHg (weighted, 14.21 ± 2.78 mmHg). Approxi-
mately 90% of the participants said that they used some type of glasses, and approximately 76%
used sunglasses.
Information on the ophthalmological history and self-reported eye diseases was available
for 14,700 subjects (Table 7). Approximately 12% of the participants used ocular medication,
and approximately 8% had a history of ocular surgery.
The frequency of self-reported eye diseases was 2.3% for glaucoma, 0.2% for surgery for reti-
nal detachment, approximately 0.4% for retinal vascular occlusions, 2.7% for strabismus,
0.12% for nystagmus and 0.05% for retinitis pigmentosa. A history of ocular trauma was re-
ported by 0.8% of the participants.
Table 5. Age distribution of participants with ophthalmological examinations in the Gutenberg Health Study at baseline (2007–2012), for the study
sample and weighted for the population of Mainz/ Mainz-Bingen.
Age range (years) Male, n (%) Female, n (%) Total, n (%)
Sample Weighted Sample Weighted Sample Weighted
35–44 1556 (10.6%) 2185.1 (14.9%) 1671 (11.4%) 2111.2 (14.4%) 3227 (22.0%) 4296.4 (29.2%)
45–54 1986 (13.5%) 2198.4 (15.0%) 1941 (13.2%) 2172.4 (14.8%) 3927 (26.7%) 4370.8 (29.7%)
55–64 1973 (13.4%) 1561.5 (10.6%) 1908 (13.0%) 1589.1 (10.8%) 3881 (26.4%) 3150.5 (21.4%)
65–74 1905 (13.0%) 1372.4 (9.3%) 1760 (12.0%) 1510.0 (10.2%) 3667 (24.9%) 2882.3 (19.6%)
All ages 7420 (50.5%) 7317.3 (49.8%) 7282 (49.5%) 7382.7 (50.2%) 14700 100%) 14700 100%)
doi:10.1371/journal.pone.0120476.t005
Table 6. Age distribution of participants without ophthalmological examination in the Gutenberg
Health Study at baseline (2007–2012).
Age range (years) Male, n (%) Female, n (%) Total, n (%)
35–44 26 (8,4%) 33 (10.7%) 59 (22.0%)
45–54 28 (9.0%) 32 (10.3%) 60 (19.4%)
55–64 60 (19.4%) 43 (13.9%) 103 (33.2%)
65–74 50 (16.1%) 38 (12.3%) 88 (24.9%)
All ages 164 (52.9%) 146 (47.1%) 310 (100%)
doi:10.1371/journal.pone.0120476.t006
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Discussion
Reliable epidemiologic data are necessary to develop prevention strategies and to plan for the
future use of medical resources in a population. Few population-based studies have examined
the extent of visual impairment and ocular health in Germany, the European country with the
largest population. The Study of Health in Pomerania (SHIP) will be able to provide only few
data because their ophthalmological examination is limited to retinal photography [13]. The
Cooperative Health Research in the Region of Augsburg (KORA) Eye study is based on a stan-
dardized interview and an eye disease questionnaire administered to 2,593 participants, with
partial validation through the treating ophthalmologist. The KORA Eye Study provides data
on only four self-reported eye diseases (corneal disease, cataracts, retinal disease and glaucoma
[14]). The Leipzig Research Center for Civilization Diseases Study (Leipziger Forschungszen-
trum für Zivilisationserkrankungen, LIFE) is another large cohort in the eastern part of Ger-
many; however, the acquisition of ophthalmic data is limited to fundus photography and
Table 7. Ocular characteristics of participants in the Gutenberg Health Study at baseline (2007–2012), for the study sample and weighted for the
population of Mainz/ Mainz-Bingen.
n1 Sample Weighted
Visual acuity2 (logMar) 14699 0.08 (0.17) [0.08–0.09] 0.07 (0.16) [0.07–0.08]
Spherical equivalent2 (diopter) 14452 -0.42 (2.43) [-0.46- (-0.38)] -0.56 (2.44) [-0.60- (-0.52)]
Intraocular pressure2 (mm Hg) 14587 14.24 (2.79) [14.20–14.29] 14.21 (2.78) [14.17–14.26]
Wearing glasses, n (%) [CI] 14700 13119 (89.2%) [88.8%-89.7%] 12677.6 (86.2%) [85.6%-86.9%]
Wearing sunglasses, n (%) [CI] 14700 11099 (75.5%) [74.8%-76.2] 11429.1 (77.8%) [77.1%-78.4%]
Ocular medication, n (%) [CI] 14700 1811 (12.3%) [11.8%-12.8%] 1640.9 (11.2%) [10.7%-11.7%]
History of ocular surgery, n (%) [CI] 14700 1141 (7.8%) [7.3%-8.2%] 1005.8 (6.8%) [6.4%-7.2%]
Self-reported eye diseases3
Cataract, n (%) [CI] 14700 97 (0.66%) [0.54%-0.80%] 84.8 (0.58%) [0.46%-0.69%]
Glaucoma, n (%) [CI] 14700 331 (2.3%) [2.0%-2.5%] 282.5 (1.9%) [1.7%-2.1%]
Suspected glaucoma, n (%) [CI] 14700 8 (0.05%) [0.02%-0.10%] 6.9 (0.05%) [0.01%-0.08%]
Ocular hypertension, n (%) [CI] 14700 27 (0.18%) [0.12%-0.26%] 23.3 (0.16%) [0.10%-0.22%]
Age-related macular degeneration, n (%) [CI] 14700 69 (0.47%) [0.36%-0.59%] 55.0 (0.37%) [0.29%-0.46%]
Retinal detachment, n (%) [CI] 14700 27 (0.18%) [0.12%-0.26%] 22.1 (0.15%) [0.09*%-0.21%]
Retinal tear, n (%) [CI] 14700 26 (0.18%) [0.12%-0.25%] 24.5 (0.17%) [0.10%-0.23%]
Retinal vessel occlusion, n (%) [CI] 14700 51 (0.35%) [0.26%-0.44%] 43.1 (0.29%) [0.21%-0.38%]
Uveitis, n (%) [CI] 14700 71 (0.48%) [0.37%-0.60%] 75.8 (0.52%) [0.39%-0.64%]
Strabismus, n (%) [CI] 14700 395 (2.69%) [2.41%-2.94] 413.6 (2.81%) [2.53%-3.10%]
Traumatic Eye disease, n (%) [CI] 14700 122 (0.83%) [0.69%-0.98%] 119.8 (0.82%) [0.67%-0.96%]
Dry eye syndrome, n (%) [CI] 14700 236 (1.61%) [1.39%-1.80%] 208.4 (1.42%) [1.23%-1.60%]
Color deﬁciency, n (%) [CI] 14700 24 (0.16%) [0.10%-0.24%] 25.5 (0.17%) [0.10%-0.25%]
Optic Neuritis, n (%) [CI] 14700 20 (0.14%) [0.07%-0.20%] 19.8 (0.13%) [0.07%-0.20%]
Allergic conjunctivitis, n (%) [CI] 14700 91 (0.62%) [0.50%-0.76%] 91.7 (0.62%) [0.49%-0.76%]
Retinitis pigmentosa, n (%) [CI] 14700 7 (0.05%) [0.02%-0.09%] 6.0 (0.04%) [0.01%-0.07%]
Nystagmus, n (%) [CI] 14700 17 (0.12%) [0.07%-0.18%] 19.8 (0.13%) [0.07%-0.20%]
n = number of subjects, CI = conﬁdence interval
1n varies between 14452 and 14700 due to missing data.
2Values are indicated as mean (standard deviation) [conﬁdence interval].
3Extracted from medical history.
doi:10.1371/journal.pone.0120476.t007
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optical coherence tomography. Thus, there was a genuine need for a comprehensive, popula-
tion-based epidemiological study of ocular diseases in Germany.
The ophthalmic branch of the GHS was designed to investigate the prevalence, incidence
and relevant risk factors associated with major ophthalmic diseases and conditions in a pre-
dominantly Caucasian population [15, 16]. Additional main goals of the study are to provide
normative data, to assess the genetic basis and associations between ophthalmological parame-
ters and diseases and to provide a biobank for future research.
The main strengths of the GHS are 1) its population-based design, 2) the multidisciplinary
approach, 3) the large size of the cohort, 4) longitudinal data acquisition and 5) genotyping in
addition to meticulous ophthalmic phenotype determination. The protocol allows us to investi-
gate the association between eye parameters and diseases in reference to a vast number of risk
factors and general health conditions, including general anthropometric data, cardiovascular
risk factors, laboratory parameters, socioeconomic status and mental health factors.
The entire sample and the first 5,000 and 10,000 participants are stratified by gender, age
(by decade) and residence (urban vs. rural); thus, any new hypothesis generated within a cer-
tain sub-cohort can be examined in the remaining sub-cohorts. Stratification by age has led to
over-representation of the elderly in the GHS cohort. The overrepresentation of the higher age
groups is intended to ensure a sufficient number of probable cardiovascular events and other
age-related diseases for statistical analysis. Therefore, the reported prevalence is standardized
for the study population (Mainz / Mainz-Bingen). This age distribution is of particular rele-
vance to ocular diseases, as most of these diseases are more prevalent in the elderly. The upper
age at baseline is limited to 74 years. Including persons who were older than 75 would have
been beneficial for assessing most age-related eye diseases and conditions. We opted to set the
age limit at the mid-seventies at baseline to ensure greater likelihood of a high percentage of re-
participation at the 5- and 10-year follow-ups.
The GHS cohort is stratified by the residences of the participants, distinguishing between
residents of the large city of Mainz and rural residents living in the Mainz-Bingen district.
When considering the difference between these two groups, one should be aware that the city
and district are very close to each other geographically. Furthermore, the recruitment area of
the study is located within the densely populated and highly industrialized region of Rhine-
Main, which is why we do not anticipate large differences between urban and rural partici-
pants, as previously reported by studies in other countries [17, 18].
Our study design, particularly the limited time for the eye examination, creates limitations.
The entire eye examination is carried out in pharmacologically unaffected pupils, which jeopar-
dizes, for example, thorough categorization of cataract stages or the detection of pseudo-
exfoliation, as well as evaluation of the retinal periphery. The slit-lamp examination does not
include characterization of the iridocorneal angle and Goldmann applanation tonometry.
We have previously published results on intraocular pressure (IOP) [19]; these findings re-
vealed a lower mean IOP than in other Caucasian samples, but similarly positive associations
between the central corneal thickness and cardiovascular risk factors. Surprisingly, we observed
a negative association between age in women and IOP.
The GHS has the potential to provide insight into numerous interdisciplinary relationships
between ocular and systemic diseases. One example is the assessment of the predictive value of
diabetic retinopathy for the future development of cardiac failure, as reported by a Japanese
group [20].
Collecting self-reported data on eye diseases is a simple method for gathering prevalence
data. However, many study participants are unaware of eye diseases, especially at early stages
(e.g., early glaucoma, mild age-related macular degeneration or mild cataract) [21, 22]. This
lack of awareness is exemplified by our analysis of age-related macular degeneration (AMD),
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in which we evaluated fundus pictures of the first 5,000 participants. Signs of early AMD were
detected in 11.9% of the overall sample and in 3.8% of the youngest sample group (aged 35–44)
[7]. The self-reported overall prevalence rate was approximately 0.5%, which is dramatically
lower than the graded prevalence. Thus, self-reported data should be validated against physi-
cian-confirmed diagnoses, eye examinations or in particular, epidemiological studies applying
standardized reading procedures (e.g. reading centers). Such grading processes are very time-
and resource-consuming, which is why future developments in (semi-) automatic data inter-
pretation will help to provide necessary data in an easier and more standardized way [23].
The self-reported prevalences of most diseases are, therefore, lower in our study than in
other studies [21, 24]. However, regarding those diseases that are much more likely to decrease
quality of life, we observed similar or even higher self-reported prevalences. Retinitis pigmen-
tosa is reported to have a prevalence of approximately 0.025 [25]. The prevalence in our sample
is 0.05% (7 of 14,700), which is twice the prevalence cited in the literature. The prevalence of
nystagmus has been estimated at between 0.033 and 0.1 [26]. However, Sarvanathan et al.
found an overall prevalence of 0.17% (17 of 10,000) in children up to 17 years old [27]. The
self-reported prevalence of nystagmus in our adult cohort was 0.12% (17 of 14,700), which is
considerably close to the estimated and measured values. We observed a strabismus coinci-
dence (2.7%) similar to those reported in several cohorts of children (2.3–2.8%) [28–31].
Thus, self-reported eye diseases still play an important role in epidemiological studies both
as exclusion criteria and to provide reliable prevalence data on eye diseases that disable or
threaten quality of life.
In the GHS, there is also a considerable chance of underestimating the prevalence rates, par-
ticularly of blind and visually impaired people. This group might be underrepresented in our
cohort due to a lower willingness to participate in a trial, which could directly result from their
impairment. Furthermore a limited underestimation of prevalence rates might be through the
subjects without eye examination. Although those participants are a small number (n = 310 or
2.1%), they are slightly older (65.3 vs. 55.0 years) and more affected by arterial hypertension
(58.1% vs. 49.6%) and diabetes mellitus (8.8% vs. 7.5%) than the examined subjects.
The GHS will provide valuable data on diseases of the eye, their risk factors and associations,
as well as their genetic background. Five-year incidence data will be available after the follow-
up tests in the study's first 5,000 participants have been completed. The entire cohort will have
completed the 5-year follow-up by March 2017. The steering committee of the GHS intends to
prolong the study, with the 10-year follow-up commencing in 2017.
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